Price T Rowe Associates Inc Portfolio Holdings

Price T Rowe Associates Inc

  • $836 Billion
  • Q2 2024

Price T Rowe Associates Inc has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $836 Billion distributed in 4459 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $61.1B, Nvidia Corp with a value of $54.9B, Apple Inc. with a value of $48.1B, Amazon Com Inc with a value of $35.1B, and Meta Platforms, Inc. with a value of $21B.

Examining the 13F form we can see an increase of $19.8B in the current position value, from $816B to 836B.

Price T Rowe Associates Inc is based out at Baltimore, MD

Below you can find more details about Price T Rowe Associates Inc portfolio as well as his latest detailed transactions.

Portfolio value $836 Billion
Technology: $278 Billion
Healthcare: $123 Billion
Financial Services: $86.2 Billion
Consumer Cyclical: $83.7 Billion
Communication Services: $76.8 Billion
Industrials: $62.5 Billion
Energy: $35.9 Billion
Consumer Defensive: $30.5 Billion
Other: $43.7 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$311M
$365,000 0.0% of portfolio
36,519
Q2 2024 Added 4.83%
$4.08B
$23 Million 0.0% of portfolio
431,446
Q2 2024 Reduced 6.7%
$3.86B
$3.84 Million 0.0% of portfolio
56,818
Q2 2024 Reduced 57.31%
$1.04B
$305,000 0.0% of portfolio
29,674
Q2 2024 Reduced 74.7%
Acelyrin Inc
-
$102,000 0.0% of portfolio
-
Q2 2024 Added 10.82%
$151M
$154,000 0.0% of portfolio
139,400
Q2 2024 Added 27.0%
$490M
$486,000 0.0% of portfolio
92,213
Q2 2024 Added 10.89%
Acres Commercial Realty Corp
-
$312,000 0.0% of portfolio
-
Q3 2023 Added 4.84%
$10.3B
$5.85 Million 0.0% of portfolio
24,218
Q2 2024 Added 1.8%
$131M
$2.53 Million 0.0% of portfolio
1,046,364
Q2 2024 Reduced 4.73%
$505M
$0 0.0% of portfolio
25,760
Q2 2024 New
$822M
$575,000 0.0% of portfolio
158,807
Q2 2024 Added 2.3%
$1.37B
$624,000 0.0% of portfolio
62,389
Q2 2024 Added 7.8%
$1.46B
$986,000 0.0% of portfolio
88,165
Q2 2024 Reduced 12.15%
$4.04B
$2.16 Million 0.0% of portfolio
31,714
Q2 2024 Added 0.24%
$333M
$220,000 0.0% of portfolio
19,668
Q2 2024 Added 22.79%
$96.8M
$99,000 0.0% of portfolio
32,735
Q2 2024 Added 224.11%
Spyre Therapeutics Inc
-
$7.24 Million 0.0% of portfolio
-
Q2 2024 Added 292.18%
$13.7B
$22.3 Million 0.0% of portfolio
139,204
Q2 2024 Reduced 0.34%
$1.07B
$111,000 0.0% of portfolio
34,217
Q2 2024 Added 36.83%
$308M
$74,000 0.0% of portfolio
10,612
Q2 2024 New
Agenus Inc
-
$350,000 0.0% of portfolio
-
Q2 2024 Reduced 94.18%
$2.9B
$41.6 Million 0.0% of portfolio
399,529
Q2 2024 Reduced 0.9%
$1.18B
$6.81 Million 0.0% of portfolio
1,040,721
Q2 2024 Reduced 37.52%
$5.25B
$5.17 Million 0.0% of portfolio
108,730
Q2 2024 Reduced 3.29%
$1.64B
$395,000 0.0% of portfolio
28,415
Q2 2024 Added 6.16%
Air Trans Svcs Group Inc
-
$445,000 0.0% of portfolio
-
Q2 2023 New
$14.4B
$18.8 Million 0.0% of portfolio
209,017
Q2 2024 Reduced 30.45%
$368M
$130,000 0.0% of portfolio
126,648
Q2 2024 Added 111.43%
$315M
$161,000 0.0% of portfolio
48,473
Q2 2024 Added 0.41%
$2.65B
$410,000 0.0% of portfolio
52,368
Q2 2024 Added 16.77%
$3.51B
$1.9 Million 0.0% of portfolio
257,185
Q2 2024 Added 14.52%
$3.63B
$399,000 0.0% of portfolio
14,007
Q2 2024 Added 21.78%
$119M
$621,000 0.0% of portfolio
620,457
Q2 2024 Reduced 2.77%
$1.34B
$1.83 Million 0.0% of portfolio
36,420
Q2 2024 Added 0.32%
$4.21B
$1.13 Million 0.0% of portfolio
40,043
Q2 2024 Added 8.76%
$11.3B
$3.68 Million 0.0% of portfolio
48,439
Q2 2024 Reduced 0.1%
$928M
$342,000 0.0% of portfolio
32,658
Q2 2024 Added 23.96%
$358M
$151,000 0.0% of portfolio
22,668
Q2 2024 Added 48.76%
$703M
$136,000 0.0% of portfolio
66,400
Q2 2024 Added 30.97%
Alto Neuroscience Inc
-
$6.9 Million 0.0% of portfolio
-
Q2 2024 Added 1.29%
$2.4B
$505,000 0.0% of portfolio
12,163
Q2 2024 Added 17.27%
$533M
$197,000 0.0% of portfolio
50,117
Q2 2024 Added 13.24%
$34.8B
$9.04 Million 0.0% of portfolio
4,409,720
Q2 2024 Reduced 7.42%
$7.17B
$10.2 Million 0.0% of portfolio
895,885
Q2 2024 Added 2.21%
American Well Corp
-
$102,000 0.0% of portfolio
-
Q2 2024 New
$6.8B
$3.75 Million 0.0% of portfolio
146,755
Q2 2024 Added 9.77%
$845M
$633,000 0.0% of portfolio
14,414
Q2 2024 Added 4.06%
$4.93B
$2.4 Million 0.0% of portfolio
47,668
Q2 2024 Added 4.39%

Summary

  • Portfolio
  • No. of Stocks 4,459
  • Current Value $836 Billion
  • Prior Value $816 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 146 stocks
  • Additional Purchases 1,848 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 834 stocks
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email